Tashiro, Hiroshi
Tanaka, Akihito
Ishii, Hideki
Motomura, Nariko
Arai, Kenji
Adachi, Takeshi
Okajima, Takashi
Iwakawa, Naoki
Kojima, Hiroki
Mitsuda, Takayuki
Hirayama, Kenshi
Hitora, Yusuke
Hayashi, Motoharu
Furusawa, Kenji
Yoshida, Ruka
Imai, Hajime
Ogawa, Yasuhiro
Kawaguchi, Katsuhiro
Murohara, Toyoaki
Article History
Received: 18 October 2019
Accepted: 28 February 2020
First Online: 9 March 2020
Compliance with ethical standards
:
: Hideki Ishii received lecture fees from Astellas Pharma Inc., Astrazeneca Inc., Daiichi-Sankyo Pharma Inc., and MSD K. K. Toyoaki Murohara received lecture fees from Bayel Pharmaceutical Co., Ltd., Daiichi-Sankyo Co., Ltd., Dainippon Sumitomo Pharma Co., Ltd., Kowa Co., Ltd., MSD K. K., Mitsubishi Tanabe Pharma Co., Nippon Boehringer Ingelheim Co., Ltd., Novartis Pharma K. K., Pfizer Japan Inc., Sanofi-aventis K. K., and Takeda Pharmaceutical Co., Ltd. Toyoaki Murohara received unrestricted research grant for Department of Cardiology, Nagoya University Graduate School of Medicine from Astellas Pharma Inc., Daiichi-Sankyo Co., Ltd., Dainippon Sumitomo Pharma Co., Ltd., Kowa Co., Ltd., MSD K. K., Mitsubishi Tanabe Pharma Co., Nippon Boehringer Ingelheim Co., Ltd., Novartis Pharma K. K., Otsuka Pharma Ltd., Pfizer Japan Inc., Sanofi-aventis K. K., Takeda Pharmaceutical Co., Ltd., and Teijin Pharma Ltd. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.